 Nemaura Medical, Inc. NASDAQ: NMRD Nemaura or the Company, a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, its non-invasive and flexible continuous glucose monitor CGM, today announced it has entered into a letter of intent with Healthimation, LLC Healthimation relating to a possible acquisition of the Healthimation business by Nemaura. 